[PDF][PDF] Extremely high variability of whole-blood tacrolimus pharmacokinetics early a 昀琀er thoracic organ transplantation
MA Sikma - Tacrolimus pharmacokinetics and toxicity in the first …, 2019 - nvic.nl
… , may signi cantly alter the disposition of tacrolimus because of adsorption to the bypass …
dosing in Chinese renal transplant recipients: a populationbased pharmacogenetics study. …
dosing in Chinese renal transplant recipients: a populationbased pharmacogenetics study. …
肝移植受者术后早期他克莫司血药浓度分析
秦寅鹏， 陈凡， 闫美玲， 张弋 - 实用器官移植电子杂志, 2020 - syqgyz.magtechjournal.com
: 目的探讨肝移植受者术后早期他克莫司(tacrolimus, Tac) 血药浓度的特点及影响因素, 为肝移植
受者的个体化治疗提供依据. 方法选取本中心肝移植受者87 例, 对肝移植受者术后14 d 内Tac 的…
受者的个体化治疗提供依据. 方法选取本中心肝移植受者87 例, 对肝移植受者术后14 d 内Tac 的…
[HTML][HTML] 药物基因检测在PLA2R 相关性膜性肾病患者治疗中的效果
谭婷婷， 郑义侯， 李芸， 曾又佳 - Journal of Southern Medical …, 2023 - ncbi.nlm.nih.gov
… Pharmacogenetic testing improves treatment responses in patients with PLA2R-…
pharmacogenetic testing for improving the efficacy and safety of treatment with cyclosporine, …
pharmacogenetic testing for improving the efficacy and safety of treatment with cyclosporine, …
器官移植术后免疫抑制剂的药物基因组学研究进展
李嘉丽， 黄民 - 药学进展, 2018 - pps.cpu.edu.cn
… used immunosuppressants after organ transplantation, including tacrolimus, cyclosporine, …
for the pharmacogenomicsguided personalized immunosuppression therapy after organ …
for the pharmacogenomicsguided personalized immunosuppression therapy after organ …
器官移植预后预测新指标: 患者他克莫司浓度个体内的变异性
李玲， 李宁， 艾紫叶， 姚亚君， 魏婉慧， 何维阳， 王彦峰… - 中国组织工程研究, 2016 - cjter.com
… The role of pharmacogenetics in the disposition of and response to tacrolimus in solid
organ transplantation. Clin … Pharmacogenetics and immunosuppressive drugs in solid …
organ transplantation. Clin … Pharmacogenetics and immunosuppressive drugs in solid …
面對腎臟移植病人難以調整的Tacrolimus 濃度與藥物劑量: 你有另一個選擇
鄭景耀， 劉媖媚， 吳明芬， 劉文雄 - 臺灣臨床藥學雜誌, 2020 - airitilibrary.com
… (TDM) is routinely implemented for individualization of the tacrolimus dose to maintain drug
efficacy and minimize the adverse reaction, which is important and urgent. The total body …
efficacy and minimize the adverse reaction, which is important and urgent. The total body …
五酯胶囊对肝, 肾移植术后他克莫司治疗影响的系统评价.
王-竹， 柳芳， 张相林 - Evaluation & Analysis of Drug-Use in …, 2021 - search.ebscohost.com
… The role of pharmacogenetics in the disposition of and response to tacrolimus in solid
organ … Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney …
organ … Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney …
[HTML][HTML] 细胞色素P450 对器官移植的影响机制研究进展
张若菡， 薛雯， 张岳， 陈洁晶， 周献青… - Advances in Clinical …, 2021 - hanspub.org
… Tacrolimus immunosuppressive drugs are widely used in transplant recipients. Its …
Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ …
Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ …
[引用][C] IATDMCT 他克莫司个体化治疗的TDM 共识(2019 版) 报告解读
高慧儿， 王姗， 闫美玲， 张弋 - 实用器官移植电子杂志, 2020 - syqgyz.magtechjournal.com
… 他克莫司是实体器官移植(solid organ transplantation,SOT)中最常用的免疫抑制剂[1-2]. … )个体
间变异大,因此应考 虑应用药物基因组学(pharmacogenomics,PG)和免 疫生物标志物,并且应进行…
间变异大,因此应考 虑应用药物基因组学(pharmacogenomics,PG)和免 疫生物标志物,并且应进行…
基因多型性及臨床因素對腎臟移植病人tacrolimus 血中濃度之影響
温俊銘 - 2018 - tdr.lib.ntu.edu.tw
… 目前核准使用於心臟,肝臟,腎 臟移植,也用於心肺聯合移植,其他實體器官移植(solid organ …
, polymorphism or pharmacogenetics and tacrolimus.所有搜索到的文獻會根據其提供的資料…
, polymorphism or pharmacogenetics and tacrolimus.所有搜索到的文獻會根據其提供的資料…